What does APOTHEEK SINT-JOZEF do?

APOTHEEK SINT-JOZEF is a logistics company in Olen. Private Limited, started on 29 March 1991, 1 establishment.

What is the address of APOTHEEK SINT-JOZEF?

The registered office of APOTHEEK SINT-JOZEF is located at Lichtaartseweg 91, 2250 Olen.

Is APOTHEEK SINT-JOZEF still active?

Yes. According to the CBE (29 October 2026) APOTHEEK SINT-JOZEF is active, legal situation “Normale toestand”, started on 29 March 1991.

Is APOTHEEK SINT-JOZEF registered on Peppol?

Yes, APOTHEEK SINT-JOZEF is registered on the Peppol network with ID 0208:0443839930.

What is the enterprise number of APOTHEEK SINT-JOZEF?

The enterprise number of APOTHEEK SINT-JOZEF is BE0443839930.

When was APOTHEEK SINT-JOZEF founded?

APOTHEEK SINT-JOZEF was founded on 29 March 1991.

Who are the directors of APOTHEEK SINT-JOZEF?

According to the 2025 annual accounts, the directors of APOTHEEK SINT-JOZEF are: Sodiap BV, Alexo BV.

Is APOTHEEK SINT-JOZEF a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 March 1991; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK SINT-JOZEF make in 2025?

APOTHEEK SINT-JOZEF posted a profit after taxes of € 39,635 in financial year 2025.

What is the revenue of APOTHEEK SINT-JOZEF?

As a small company, APOTHEEK SINT-JOZEF is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 232,972.

How much does an employee at APOTHEEK SINT-JOZEF earn?

The average wage cost per full-time employee at APOTHEEK SINT-JOZEF was € 76,700 in 2025: staff costs of € 176,403 for 2.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK SINT-JOZEF have?

According to the 2025 annual accounts, APOTHEEK SINT-JOZEF has 2.3 full-time equivalents (FTE).

APOTHEEK SINT-JOZEF (Private Limited) - Olen

Dossier APOTHEEK SINT-JOZEF, printed on 29 October 2026 from databakkes.be/en/0443839930/apotheek-sint-jozef. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK SINT-JOZEF from Olen, company number BE0443839930, closed financial year 2025 with a result of € 39,635 after tax. For that financial year APOTHEEK SINT-JOZEF recorded a gross margin of € 232,972 and equity of € 1.5 million. Compared with financial year 2024, the result moved from € 31,440 to € 39,635. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 12, 2026.

What it is worth Growing

€ 1.5 million

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 39,635

▲ 26% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 5,186

▲ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.5 million.

People and assets in 2025

Full-time equivalents

2.3

▲ 0.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 176,403

▲ 17% vs 2024

€ 76,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 2,729

▼ 1% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 94,123

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 26,717

▲ 39% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 91,970 Gross margin 2022: € 91,970 First fiscal year in the series	€ 162,566 Gross margin 2023: € 162,566 ▲ 77% vs 2022 (€ 91,970) Favourable step	€ 177,768 Gross margin 2024: € 177,768 ▲ 9% vs 2023 (€ 162,566) Favourable step	€ 232,972 Gross margin 2025: € 232,972 ▲ 31% vs 2024 (€ 177,768) Favourable step	▲ 31%
Profit after taxes	€ -2,421 Profit after taxes 2022: € -2,421 First fiscal year in the series	€ 19,329 Profit after taxes 2023: € 19,329 ▲ € 21,750 vs 2022 (€ -2,421) Favourable step	€ 31,440 Profit after taxes 2024: € 31,440 ▲ 63% vs 2023 (€ 19,329) Favourable step	€ 39,635 Profit after taxes 2025: € 39,635 ▲ 26% vs 2024 (€ 31,440) Favourable step	▲ 26%
Equity	€ 2,438,010 Equity 2022: € 2,438,010 First fiscal year in the series	€ 1,442,339 Equity 2023: € 1,442,339 ▼ 41% vs 2022 (€ 2,438,010) Unfavourable step	€ 1,473,780 Equity 2024: € 1,473,780 ▲ 2% vs 2023 (€ 1,442,339) Favourable step	€ 1,513,415 Equity 2025: € 1,513,415 ▲ 3% vs 2024 (€ 1,473,780) Favourable step	▲ 3%
Total debts	€ 125,667 Total debts 2022: € 125,667 First fiscal year in the series	€ 135,149 Total debts 2023: € 135,149 ▲ 8% vs 2022 (€ 125,667) Unfavourable step	€ 113,319 Total debts 2024: € 113,319 ▼ 16% vs 2023 (€ 135,149) Favourable step	€ 120,841 Total debts 2025: € 120,841 ▲ 7% vs 2024 (€ 113,319) Unfavourable step	▲ 7%
Cash	€ 4,171 Cash 2022: € 4,171 First fiscal year in the series	€ 4,921 Cash 2023: € 4,921 ▲ 18% vs 2022 (€ 4,171) Favourable step	€ 4,896 Cash 2024: € 4,896 ▼ 1% vs 2023 (€ 4,921) Unfavourable step	€ 5,186 Cash 2025: € 5,186 ▲ 6% vs 2024 (€ 4,896) Favourable step	▲ 6%
Land & buildings	€ 192,189 Land & buildings 2022: € 192,189 First fiscal year in the series	€ 166,267 Land & buildings 2023: € 166,267 ▼ 13% vs 2022 (€ 192,189) Unchanged	€ 140,345 Land & buildings 2024: € 140,345 ▼ 16% vs 2023 (€ 166,267) Unchanged	€ 114,658 Land & buildings 2025: € 114,658 ▼ 18% vs 2024 (€ 140,345) Unchanged	▼ 18%
Retained profit	€ 2,419,410 Retained profit 2022: € 2,419,410 First fiscal year in the series	€ 1,423,739 Retained profit 2023: € 1,423,739 ▼ 41% vs 2022 (€ 2,419,410) Unfavourable step	€ 1,455,180 Retained profit 2024: € 1,455,180 ▲ 2% vs 2023 (€ 1,423,739) Favourable step	€ 1,494,815 Retained profit 2025: € 1,494,815 ▲ 3% vs 2024 (€ 1,455,180) Favourable step	▲ 3%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 1,015,000 Dividend 2023: € 1,015,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 1,015,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 2,563,676 Balance sheet total 2022: € 2,563,676 First fiscal year in the series	€ 1,577,488 Balance sheet total 2023: € 1,577,488 ▼ 38% vs 2022 (€ 2,563,676) Unchanged	€ 1,587,099 Balance sheet total 2024: € 1,587,099 ▲ 1% vs 2023 (€ 1,577,488) Unchanged	€ 1,634,255 Balance sheet total 2025: € 1,634,255 ▲ 3% vs 2024 (€ 1,587,099) Unchanged	▲ 3%
Employees (FTE)	2 Employees (FTE) 2022: 2 First fiscal year in the series	2 Employees (FTE) 2023: 2 Unchanged (2) Unchanged	2 Employees (FTE) 2024: 2 Unchanged (2) Unchanged	2.3 Employees (FTE) 2025: 2.3 ▲ 0.3 vs 2024 (2) Unchanged	▲ 0.3

Key figures of APOTHEEK SINT-JOZEF, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK SINT-JOZEF?

What happened at APOTHEEK SINT-JOZEF in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 12, 2026 New annual accounts for financial year 2025: profit of € 39,635 (▲ 26% vs 2024). Source: NBB ↗
2022 Alexo BV became a director. NBB
2020 Sodiap BV became a director. NBB
Apr 26, 1991 New establishment in Olen. KBO
Mar 29, 1991 Start of the company according to the CBE. KBO

In short

From € 2,421 loss in 2022 to € 39,635 profit in 2025.

Paid € 34,451 in corporate taxes since 2022.

Best year ever: 2025, with € 39,635 profit.

On average € 101,300 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

SODIAP 100%

The stake of SODIAP comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK SINT-JOZEF

Behind APOTHEEK SINT-JOZEF are Sodiap BV and Alexo BV. The shares are held by SODIAP (100%).

Directors

According to the 2025 annual accounts

Sodiap BV

Managing director · represented by Tom Goderis

Also active at: SDC, HC Pharma, APOTHEEK JENNE, Apotheek de Lisseweg, Apotheek Seurinck, APOTHEEK SCARPHOUT, C.E. FARMA, SANIFAR +24 more

since 2020

Alexo BV

Chairman of the board · represented by Olivier Delaere

Also active at: SDC, HC Pharma, SODIAP, APOTHEEK JENNE, PANNOC CHEMIE, Apotheek de Lisseweg, Apotheek Seurinck, APOTHEEK SCARPHOUT +34 more

since 2022

Shareholders

SODIAP

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Lichtaartseweg 91

2250 Olen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Jeugdklub Jejo

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0443.839.930

VAT number

BE 0443.839.930

Registered office

Lichtaartseweg 91, 2250 Olen

Names & denominations

APOTHEEK SINT-JOZEF

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

29 March 1991

Peppol

Active · Active since 6 Jun 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK SINT-JOZEF

Financials

What happened to APOTHEEK SINT-JOZEF?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions